American Beacon Advisors, Inc. Biogen Inc. Transaction History

American Beacon Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$278.5 - $352.75 $127,831 - $161,912	-459 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $17,610 - $23,029	60 Added 15.04%	459 $162,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $9,884 - $13,980	38 Added 10.53%	399 $0
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $12,613 - $14,127	41 Added 12.81%	361 $0
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $89,968 - $105,500	320	320 $0

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of American Beacon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on American Beacon Advisors, Inc. with notifications on news.